Dr. Samata Singhi is a clinical safety and risk management physician with expertise in child neurology. They served as the Associate Medical Director for Global Drug Safety at Biogen from 2022 to 2023 and are currently a Senior Principal Scientist in drug safety at Merck. Dr. Singhi has held academic positions, including Assistant Professor of Neurology at The Johns Hopkins University School of Medicine and Director of the Epilepsy Monitoring Unit at the Kennedy Krieger Institute from 2018 to 2022. Their educational background includes an MD from Case Western Reserve University School of Medicine and a Master's degree in Health Economics from the London School of Economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices